SL

Supreme Pharmaceuticals Inc. (the "Company") (TSX VENTURE:SL)(PINKSHEETS:SPRWF)
notes that in respect to its prior press release on Friday April 4, 2014, the
Company will be utilizing the full 7 business days to complete and conclude the
due diligence period. This means that the Company will report news on Tuesday,
April 15, 2014 with a final decision on the South Okanagan producing medical
marijuana facility.


We apologize for the misperception from the prior press release that a decision
would be made as of April 10, 2014.


The process thus far has been positive and the process is moving ahead smoothly.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.


FORWARD-LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the
words "anticipate", "continue", "estimate", "expect", "may", "will", "project",
"should", "believe" and similar expressions are intended to identify
forward-looking statements. Although the Company believes that the expectations
and assumptions on which the forward-looking statements are based are
reasonable, undue reliance should not be placed on the forward-looking
statements because the Company can give no assurance that they will prove to be
correct. Since forward-looking statements address future events and conditions,
by their very nature they involve inherent risks and uncertainties. These
statements speak only as of the date of this News Release. Actual results could
differ materially from those currently anticipated due to a number of factors
and risks including various risk factors discussed in the Company's disclosure
documents which can be found under the Company's profile on www.sedar.com. This
News Release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Supreme Pharmaceuticals Inc.
#772 Alastair Ross Technology Centre
3553 - 31st Street NW, Calgary, Alberta, T2L 2K7
Phone: (647) 340-6744
Email: info@supremepharmaceuticals.com
Website: www.supremepharmaceuticals.com

(TSXV:SL)
Historical Stock Chart
From Jun 2024 to Jul 2024

(TSXV:SL)
Historical Stock Chart
From Jul 2023 to Jul 2024